Leukemia, Myelogenous, Acute
5 clinical trials · Condition
◉ Watch Leukemia, Myelogenous, Acute
| Record | Firm | Date |
|---|---|---|
| LCI-HEM-SPEC-001: Tissue Collection for Genetic Analysis of Acute Myelogenous Leukemia (NCT01999556) | Wake Forest University Health Sciences | 2013-11-01 |
| A Phase I Clinical Trial of OXi4503 for Relapsed and Refractory AML and MDS (NCT01085656) | University of Florida | 2011-02-01 |
| Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia (NCT01158885) | Therapeutic Advances in Childhood Leukemia Consortium | 2010-08-01 |
| Haploidentical Natural Killer Cells to Treat Refractory or Relapsed Acute Myelogenous Leukemia (AML) (NCT01106950) | Masonic Cancer Center, University of Minnesota | 2010-07-01 |
| Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies (NCT00619879) | Ann & Robert H Lurie Children's Hospital of Chicago | 2007-03-26 |
Track Leukemia, Myelogenous, Acute automatically
Every clearance here is in the API, with alerts when new ones post.